| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant ...
PADCEV plus Keytruda is the first and only approved perioperative treatment regimen that can significantly improve survival ove...
Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement wi...
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.
Saudi Arabia has committed to purchasing hundreds of U.S.-made tanks, underlining an expansive defense and economic partnership...
https://www.bloomberg.com/news/articles/2025-11-18/pfizer-kicks-off-us-dollar-bond-sale-to-help-fund-metsera-deal
Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board ov...
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com...
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.